NYSE: EPAMEpam Systems Inc Stock
$147.16-0.12 (-0.08%)
Updated Apr 17, 2025
EPAM Price
$147.16
Fair Value Price
N/A
Market Cap
$8.37B
52 Week Low
$138.15
52 Week High
$269.00
P/E
18.56x
P/B
2.31x
P/S
2.83x
PEG
2.17x
Dividend Yield
N/A
Revenue
$4.73B
Earnings
$454.53M
Gross Margin
30.7%
Operating Margin
12.36%
Profit Margin
9.6%
Debt to Equity
0.31
Operating Cash Flow
$559M
Beta
1.37
Next Earnings
May 7, 2025
Ex-Dividend
N/A
Next Dividend
N/A
EPAM Overview
EPAM Systems, Inc. manufactures custom software and provides consulting services in the U.S. and internationally. It areas of operation are software development, custom application development, application testing, enterprise application platforms, application maintenance, and support and infrastructure management. EPAM was founded in 1993 and is headquartered in Newtown, PA.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine EPAM's potential to beat the market
CHold
- Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More
Zen Rating Component Grades
A
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Information Technology Service
Industry Rating
A
EPAM
Ranked#28 of 58
Ranked#28 of 58
Be the first to know about important EPAM news, forecast changes, insider trades & much more!
EPAM News
Overview
Due Diligence Score
–
Industry Average (37)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how EPAM scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
EPAM ($147.16) is trading above its intrinsic value of $66.59, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
EPAM is good value based on its earnings relative to its share price (18.56x), compared to the US market average (27.98x)
P/E vs Market Valuation
EPAM is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 30 more EPAM due diligence checks available for Premium users.
Valuation
EPAM price to earnings (PE)
For valuing profitable companies with steady earnings
Company
18.56x
Industry
26.95x
Market
27.98x
EPAM is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
EPAM is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
EPAM price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
2.31x
Industry
4.68x
EPAM is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
EPAM price to earnings growth (PEG)
For valuing profitable companies with growth potential
EPAM is poor value relative... subscribe to Premium to read more.
PEG Value Valuation
EPAM's financial health
Profit margin
Revenue
$1.2B
Net Income
$103.3M
Profit Margin
8.3%
EPAM's Earnings (EBIT) of $584.41M... subscribe to Premium to read more.
Interest Coverage Financials
EPAM's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$4.8B
Liabilities
$1.1B
Debt to equity
0.31
EPAM's short-term assets ($2.43B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
EPAM's short-term assets ($2.43B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
EPAM's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
EPAM's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$130.3M
Investing
-$845.9M
Financing
$1.3M
EPAM's operating cash flow ($559.17M)... subscribe to Premium to read more.
Debt Coverage Financials
EPAM vs Information Technology Service Stocks
Epam Systems Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.